Recent NewS
BioPub Webcast Access
This forum will be home to all BioPub Webcast Access info.
New BioPub Website Tutorial (work in progress)
New BioPub Website Tutorial LOGIN: Using Laptop PC and Chrome: Click on My Account and Select Login from the Drop-down. Click the Remember Me box …
Introducing Ventripoint: Secrets of the Unknown Ventricle
Introducing Ventripoint: Secrets of the Unknown Ventricle By Tony Pullen, Editor-at-Large [Editor’s foreword: Ventripoint CEO George Adams will be guest for a BioPub webcast at …
All Hail Hector the BioBull: The New BioPub Logo
We couldn’t hold back any longer and decided not to wait until the launch of BioPub V3.0 for the great unveiling of the new BioPub …
Is Summit’s Ridinilazole a Threat to Acurx’s Ibezapolstat in the C.difficile Space?
David Luci, CPA, JD Acurx Cofounder and Managing Partner Is Summit’s Ridinilazole a Threat to Acurx’s Ibezapolstat in the C.difficile Space? Another reason to say “I Love …
BioPub TV: Webcast Schedule for August 2020
Many switchbacks on the road ahead that remains for August……here’s an update on what to plan for. Friday, 14 August, Noon EST: Leading-edge fullerene chemistry …
Ten Good Reasons to Invest Now Pre-Market in Acurx Pharmaceuticals
As possibly the filthiest river on Earth, the Ganges has three bacteriophages for every bacterium. Which is probably why you don’t die from drinking or …
The Road Ahead: This Week at BioPub
Stay with us this week at BioPub as we prepare, Friday, to introduce you to a novel investing idea that represents a foray outside biotech. August …
Really Too. Open Table, August 2020
The scary outcome that’s become increasingly a reality for certain Covid-19 patients. In NYT this morning. Bring on the ifenprodil! (Disclosure: Long Algernon) By Denise …
New from Tony Pullen on Altum/BetterLife
CEO Ahmed Douroudian, PhD Covid Canada Revisited by Tony Pullen Dear readers, many of you will recall that I became involved with a company called …
Readers Write: Can NervGen Restore My Brother-in-Law’s Heath? A Narrative of Plight and Hope by Rebecca Adams
Jon, the author’s brother-in-law. Lonely are the brave. Readers Write: Can NervGen Restore My Brother-in-Law Jon’s Health? A Narrative of Plight and Hope by Rebecca …
Bucky Bucks? Highbrow Nanocarbon Chemistry May Be a High-Dollar Investing Opportunity for BioPub Readers
“When I am working on a problem, I never think about beauty but when I have finished, if the solution is not beautiful, I know …
Join The BioPub
Community
Register now and gain access to our medical and science forums.
Join The BioPub
Community
Register now and gain access to our medical and science forums.
BIOPUB Webcasts
BioPub offers regular webcasts and townhall meetings to discuss the companies we are following. Webcasts are normally attended by top management of the spotlighted company and gives our BioPub subscribers an opportunity to ask pertinent questions about their business. This type of direct access that BioPub provides to CEOs, CFOs and CMOs cannot be found anywhere else!
Be apart of our exclusive team
BIOPUB WebcastS
BioPub offers regular webcasts and townhall meetings to discuss the companies we are following. Webcasts are normally attended by top management of the spotlighted company and gives our BioPub subscribers an opportunity to ask pertinent questions about their business. This type of direct access that BioPub provides to CEOs, CFOs and CMOs cannot be found anywhere else!
Be apart of our exclusive team
COMMUNICATE
OVERCOME
INTERACT
Subscribe For More Content
Get email updates sent straight to your inbox so you can
keep up to date with all the latest news in biotech investment!
keep up to date with all the latest news in biotech investment!
Subscribe For More Content
Get email updates sent straight to your inbox so you can keep up to date with all the latest news in biotech investment!
BioPub Team
- Founders: KSS, MD, PhD, (New York) and Alan Harris (London), 2013
- Editor-in-Chief and Publisher: KSS, MD, PhD, FACP
- Editor Board Chairman: Jonathan Coulborn, MBA
- Managing Editor: YVR Trader
- Editor-at-Large: Tony Pullen
- Associate Editors: cw99, MD and Paul Harte
- Associate Editor (Medical Literature): OneMdcn
- Contributing Editor: Cleveland
- Editor-at-Large: Glenn Newberry
- Editorial Board Chairman: Jonathan Coulborn, MBA
EDITORIAL BOARD
- Tom Nall: Tampa, Florida
- cw99, MD: Austin, TX
- KSS, MD, PhD: ex officio
- Paul Harte: San Franciso, CA
- YVR Trader: Vancouver, BC
- Melanie, MS: New York, NY
WEBSITE MAP
MY ACCOUNT
BioPub Team
- Founders: KSS, MD, PhD, (New York) and Alan Harris (London), 2013
- Editor-in-Chief and Publisher: KSS, MD, PhD, FACP
- Editor Board Chairman: Jonathan Coulborn, MBA
- Managing Editor: YVR Trader
- Editor-at-Large: Tony Pullen
- Associate Editors: cw99, MD and Paul Harte
- Associate Editor (Medical Literature): OneMdcn
- Contributing Editor: Cleveland
- Editor-at-Large: Glenn Newberry
- Editorial Board Chairman: Jonathan Coulborn, MBA
EDITORIAL BOARD
- Tom Nall: Tampa, Florida
- cw99, MD: Austin, TX
- KSS, MD, PhD: ex officio
- Paul Harte: San Franciso, CA
- YVR Trader: Vancouver, BC
- Melanie, MS: New York, NY
Company Contact
-
BioPub, PMB #522,
4711 Hope Valley Road,
Suite 4F, Durham, NC 27707
